Biomea Fusion Stock Quote BMEA - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

8.60

Bid

8.59

Ask

8.61

Volume

323,362

8.09 Day's Range 8.8243

3.61 52 Week Range 22.74

Market Cap

311.407M

Previous Close

8.26

Open

8.17

Last Trade

8.6

Last Trade Time

15:25:59

Financial Volume

$ 2,756,911

VWAP

8.5258

Average Volume (3m)

695,698

Shares Outstanding

36,210,167

Dividend Yield

PE Ratio

-2.65

Earnings Per Share (EPS)

-3.24

Revenue

Net Profit

-117.26M

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bi... Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.biomeafusion.com

Headquarters

Wilmington, Delaware, USA

Founded

Biomea Fusion Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BMEA. The last closing price for Biomea Fusion was $8.26. Over the last year, Biomea Fusion shares have traded in a share price range of $ 3.61 to $ 22.74.

Biomea Fusion currently has 36,210,167 shares outstanding. The market capitalization of Biomea Fusion is $299.10 million. Biomea Fusion has a price to earnings ratio (PE ratio) of -2.65.

FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.06	14.0583554377	7.54	8.8243	7.32	353885	7.88443363	CS
4	2.69	45.5160744501	5.91	8.8243	5.79	630370	7.44977516	CS
12	3.52	69.2913385827	5.08	8.8243	4.15	695698	5.97928577	CS
26	-9.09	-51.3849632561	17.69	17.89	3.61	1053957	8.03044751	CS
52	-6.41	-42.7048634244	15.01	22.74	3.61	1046424	11.5077276	CS
156	-2.01	-18.9443920829	10.61	43.69	2.84	572275	15.63173556	CS
260	-11.4	-57	20	43.69	2.84	516968	15.64222673	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OMEXOdyssey Marine Exploration Inc	$ 1.4099 (184.08%)	315.68M
PRTGPortage Biotech Inc	$ 10.10 (122.96%)	50.37M
VVOSVivos Therapeutics Inc	$ 4.6599 (66.43%)	71.9M
APLTApplied Therapeutics Inc	$ 7.535 (62.04%)	48.22M
XCHXCHG Ltd	$ 17.73 (59.73%)	1.2M
GLMDGalmed Pharmaceuticals Ltd	$ 6.6935 (-55.67%)	5.92M
DTSSDatasea Inc	$ 2.0561 (-30.06%)	1.16M
KAKineta Inc	$ 0.598 (-27.86%)	326.24k
LKCOLuokung Technology Corporation	$ 2.66 (-27.12%)	140.89k
ALLRAllarity Therapeutics Inc	$ 2.20 (-26.42%)	1.41M
OMEXOdyssey Marine Exploration Inc	$ 1.4099 (184.08%)	315.68M
WBUYWeBuy Global Ltd	$ 0.1833 (58.02%)	239.43M
NVDANVIDIA Corporation	$ 114.733 (-0.74%)	237.71M
SQQQProShares UltraPro Short QQQ	$ 8.255 (-0.30%)	164.12M
LUNRIntuitive Machines Inc	$ 7.605 (40.83%)	132.91M